Mechanism of direct bicarbonate transport by the CFTR anion channel  by Tang, Lin et al.
(2009) 115–121
www.elsevier.com/locate/jcfJournal of Cystic Fibrosis 8Mechanism of direct bicarbonate transport by the CFTR anion channel
Lin Tang, Mohammad Fatehi 1, Paul Linsdell ⁎
Department of Physiology & Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada
Received 9 September 2008; received in revised form 20 October 2008; accepted 20 October 2008
Available online 18 November 2008Abstract
Background: CFTR contributes to HCO3
− transport in epithelial cells both directly (by HCO3
− permeation through the channel) and indirectly
(by regulating Cl−/HCO3
− exchange proteins). While loss of HCO3
− transport is highly relevant to cystic fibrosis, the relative importance of direct
and indirect HCO3
− transport it is currently unknown.
Methods: Patch clamp recordings from membrane patches excised from cells heterologously expressing wild type and mutant forms of human
CFTR were used to isolate directly CFTR-mediated HCO3
− transport and characterize its functional properties.
Results: The permeability of HCO3
− was ~25% that of Cl− and was invariable under all ionic conditions studied. CFTR-mediated HCO3
− currents
were inhibited by open channel blockers DNDS, glibenclamide and suramin, and these inhibitions were affected by mutations within the channel
pore. Cystic fibrosis mutations previously associated with disrupted cellular HCO3
− transport did not affect direct HCO3
− permeability.
Conclusions: Cl− and HCO3
− share a common transport pathway in CFTR, and selectivity between Cl− and HCO3
− is independent of ionic
conditions. The mechanism of transport is therefore effectively identical for both ions. We suggest that mutations in CFTR that cause cystic
fibrosis by selectively disrupting HCO3
− transport do not impair direct CFTR-mediated HCO3
− transport, but may predominantly alter CFTR
regulation of other HCO3
− transport pathways.
© 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Bicarbonate; CFTR; CF mutation; Permeation; Site directed mutagenesis; Electrophysiology1. Introduction
Cystic fibrosis (CF) is a disease of deficient epithelial anion
transport, resulting from genetic mutations that cause a loss of
function of the cystic fibrosis transmembrane conductance reg-
ulator (CFTR) [1]. CFTR is an anion-selective ion channel that
forms the predominant Cl− conductance in the apical membrane
of many different epithelial cells, and as a result loss of CFTR
function leads directly to deficient Cl− secretion from CF epi-
thelia [2].
Like most anion channels, CFTR shows quite low selectivity
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doi:10.1016/j.jcf.2008.10.004transport of many different small anions [3]. In fact, direct
permeation of both glutathione (GSH) [4,5] and bicarbonate
(HCO3
−) anions [2,6] through the CFTR channel pore have been
proposed to be physiologically relevant. Bicarbonate secretion,
like Cl− secretion, likely contributes to fluid secretion andmucus
hydration [2,7]; HCO3
− secretion may also regulate the pH of
secreted fluid [8]. It is currently debated whether loss of Cl−
secretion or loss of HCO3
− secretion is more relevant to CF
disease [2,9]. Central to this debate is the report that the severity
of CF disease symptoms associated with different CFTR muta-
tions, at least as relates to pancreatic function, was correlated
with their ability to support HCO3
− transport, not Cl− transport, in
heterologous expression systems [10]. Most strikingly, some
mutations associated with severe, pancreatic insufficient CF
symptoms abolished HCO3
− transport while retaining near nor-
mal levels of Cl− transport [10].
It has been known for over 10 years that CFTR can directly
mediate HCO3
− transport [11–13]. It is generally reported that
CFTR has a HCO3
− permeability of around 20% that of Cl−
(PHCO3/PCl~0.2) [6]. However this value, which is widelyd by Elsevier B.V. All rights reserved.
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− secretion from re-
views [6,8,14] to mathematical modeling studies [15,16], comes
from older work that used highly non-physiological ionic con-
ditions to demonstrate HCO3
− currents carried byCFTR [11–13].
More recently, it has been suggested that CFTR shows a
“dynamic” selectivity and can switch between HCO3
− permeable
and HCO3
− impermeable states depending on conditions
[17,18]. This suggestion raises the important question
of whether CFTR transports Cl− and HCO3
− ions by common
or separate mechanisms. While the molecular mechanism of
Cl− transport has been well studied [3], detailed investigations
of direct HCO3
− transport by CFTR are lacking.
Understanding the role of CFTR in epithelial HCO3
− trans-
port is complicated by the fact that CFTR can interact with Cl−/
HCO3
− exchange proteins of the SLC26 family [19]. Activity of
these exchangers in the apical membrane has been shown to
contribute to HCO3
− secretion by a number of different epithelial
cell types [14,20–22]. Furthermore, reciprocal regulation has
been described, whereby some SLC26 proteins up- or down-
regulate CFTR activity [21,23] and CFTR upregulates SLC26
activity [19,24]. In spite of the presumed importance of de-
ficient HCO3
− secretion to CF pathophysiology, the relative
contributions of direct HCO3
− transport via CFTR versus indi-
rectly CFTR-regulated HCO3
− transport via Cl−/HCO3
−
exchange proteins to epithelial HCO3
− secretion are not known
[25].
Because the reported HCO3
− permeability is low and bio-
logical solutions contain high concentrations of Cl−, it is not
possible to separate HCO3
− currents from Cl− currents electri-
cally under physiological ionic conditions. CFTR-dependent
HCO3
− transport is therefore often measured using indirect
methods, such as changes in pH [10,18]. This makes it even
more difficult to separate direct from indirect HCO3
− transport.
In the present study we have used patch clamp recordings from
excised, inside-out membrane patches removed from cells het-
erologously expressing a very high density of CFTR, in order
to isolate direct CFTR-mediated HCO3
− transport. Furthermore,
assuming that CFTR is involved in HCO3
− secretion, we have
studied the movement of HCO3
− ions through CFTR from the
intracellular to the extracellular side of the membrane.
2. Methods
Experiments were carried out on baby hamster kidney cells
stably transfected with wild type or mutant forms of human
CFTR [26]. Mutagenesis was carried out using the QuikChange
system (Stratagene, La Jolla, CA, USA) as described previously
[27] and verified by DNA sequencing. Macroscopic and single
channel patch clamp recordings were made from inside-out
membrane patches excised from these cells, as described in
detail previously for currents carried by Cl− [27,28] and other
anions [4,29]. Following patch excision and recording of back-
ground currents, CFTR channels were activated by exposure to
protein kinase A catalytic subunit (PKA; 20–80 nM) plus
MgATP (1 mM) in the cytoplasmic solution. No PKA- or ATP-
dependent currents were identified in untransfected cells under
any of the ionic conditions studied.During inside-out patch recordings, intracellular (bath) solu-
tions contained 50–150 mM NaHCO3
− or (in Fig. 3A) 50 mM
NaCl, and extracellular (pipette) solutions contained 0–150 mM
NaCl plus 0–50 mM Na gluconate as the predominant salts.
In addition, all solutions contained 2 mM MgCl2 and 10 mM
TAPS (N-tris[hydroxymethyl]methyl-3-aminopropane-
sulfonate) buffer, and were adjusted to pH 8.3 using NaOH.
Bicarbonate solutions were made fresh every 2 h, bubbled with
5% CO2 immediately before use, and maintained at high pH
(8.3) to minimize decomposition into H2O and CO2. Control
experiments indicated no change in experimental results or in
measured solution pH over the time course of the experiments
under these conditions. All chemicals were obtained from
Sigma-Aldrich (Oakville, ON, Canada) except PKA (Promega,
Madison, WI, USA).
Current traces were filtered at 50–100 Hz using an 8-pole
Bessel filter, digitized at 250 Hz–1 kHz, and analyzed using
pCLAMP8 software (Molecular Devices, Sunnyvale, CA,
USA). Macroscopic current–voltage (I–V) relationships were
constructed using depolarizing voltage ramp protocols, with a
rate of change of voltage of 100 mV s−1 [29]. Background (leak)
currents recorded before addition of PKA and ATP have been
subtracted digitally, leaving uncontaminated CFTR currents
[29]. Membrane voltages were corrected for liquid junction
potentials calculated using pCLAMP8 software. The macro-
scopic current reversal potential (Vrev) was estimated by fitting
a polynomial function to the leak-subtracted I–V relationship
and was used to calculate the permeability of HCO3
− relative to
that of Cl− (PHCO3/PCl) according to the equation:
V rev ¼ ðRT=FÞln½ðPHCO3½HCO3i
þ PCl½CliÞ=ðPCl½CloÞ ð1Þ
where [X]i and [X]o represent intracellular and extracellular
anion concentrations respectively, and R, T and F have their
usual thermodynamic meanings.
Experiments were carried out at room temperature, 21–
24 °C. Values are presented as mean±S.E.M. Tests of sig-
nificance were carried out using a Student's two-tailed t test.3. Results
3.1. Bicarbonate permeability of CFTR
Reported HCO3
− permeability values for CFTR have usually
been calculated from the current reversal potential measured
with a high concentration of HCO3
− on one side of the mem-
brane and Cl− on the opposite side [11–13,30]. This kind of ex-
periment is illustrated in Fig. 1A, showing the macroscopic
I–V relationship for CFTR in an inside-out membrane patch,
with 150 mM HCO3
− in the intracellular solution and 154 mM
Cl− in the extracellular solution. Under these conditions the
measured current reversal potential was −31.0±2.3 mV (n=7),
corresponding to a relative HCO3
− permeability, PHCO3/PCl,
of 0.286±0.029 (n=7) according to Eq. (1). As shown in
Fig. 1B, practically the same result is obtained when intra-
cellular [HCO3
−] is reduced to 50 mM (with extracellular [Cl−]
Fig. 1. Bicarbonate permeability of CFTR (A–C) Example leak-subtracted macroscopic I–V relationships for wild type CFTR under different ionic conditions, as
indicated: in (A) 150 mM HCO3
− intracellular, 154 mM Cl− extracellular; in (B) 50 mM HCO3
− intracellular, 54 mM Cl− extracellular; and in (C) 50 mM HCO3
−
intracellular, 4 mM Cl− +50 mM gluconate extracellular. In all cases the intracellular solution also contained 4 mM Cl−. Under each of these conditions, negative
currents (representing anion efflux across the membrane) are carried predominantly by the movement of HCO3
− ions. (D) Example single channel currents carried by
HCO3
− efflux under the same ionic conditions used in (C), at membrane potentials of 0 mVand −60 mVas indicated. The closed state of the channel is indicated by the
line to the left. (E) Mean single channel I–V relationship measured under these conditions. Standard errors are smaller than the size of the symbols and hence not
shown. Mean of data from 3–5 patches.
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was −30.7±2.9 mV (n=4), corresponding to a PHCO3/PCl of
0.250±0.037 (n=4). Unfortunately, stable measurable HCO3
−
currents could not be obtained with lower HCO3
− concentrations.
Nevertheless, results from this limited range of concentrations
suggests that HCO3
− permeability is not strongly concentration-
dependent.
In order to examine the functional properties of the current
carried by HCO3
− ions that is associated with CFTR activity, we
wanted to isolate HCO3
− currents carried by a relatively low
concentration of HCO3
− in the intracellular solution. Fig. 1C
shows an example of current carried by 50 mM intracellular
HCO3
−when the [Cl−] in the extracellular solutionwas decreased
to 4 mM by replacement with the impermeant anion gluconate.
Under these conditions, current is carried by anion efflux across
much of the voltage range, with the reversal potential being
+35.0±1.1 mV (n=13), corresponding to a PHCO3/PCl of
0.239±0.014 (n=13). Again this is consistent with HCO3
−
permeability being quite independent of ionic conditions. To
confirm that these currents, which are presumably carried pre-
dominantly by the efflux of HCO3
−, were associated with CFTR
we used the specific inhibitor CFTRinh-172. As shown in Fig. 2,
the inhibitor was able to block HCO3
− efflux currents with anapparent Kd of 0.63 μM, with currents being N90% blocked at
concentrations above 10 μM. Furthermore, under these same
ionic conditions, unitary currents carried by HCO3
− could be
observed (Fig. 1D). The mean unitary current–voltage relation-
ship measured under these conditions shown in Fig. 1E; the
slope of individual current–voltage relationships from different
patches had a mean conductance of 5.3±0.1 pS (n=4), similar
to values previously reported [11–13].
3.2. Block of bicarbonate currents
Chloride permeation through CFTR is inhibited by a broad
range of substances that block the open channel pore [3]. Three
examples of blockers with relatively well understood molecular
mechanisms of action are the disulfonic stilbene DNDS [31], the
sulfonylurea glibenclamide [31], and the large polysulfonic acid
suramin [32]. Initially we compared the ability of these three
blockers to inhibit currents carried by Cl− or HCO3
− efflux under
similar ionic conditions (Fig. 3). These experiments used 50 mM
NaCl or NaHCO3 in the intracellular solution, and 50 mM Na
gluconate in the extracellular solution. As expected, DNDS
(100 μM), glibenclamide (30 μM) and suramin (10 μM) each
potently inhibited currents carried by Cl− efflux (Fig. 3A). These
Fig. 2. Block of bicarbonate efflux by the specific CFTR inhibitor CFTRinh-172.
(A) Example leak-subtracted I–V relationship recorded under the same ionic
conditions used in Fig. 1C, illustrating current carried by HCO3
− efflux. Currents
were recorded before (control) and following addition of 3 μM CFTRinh-172 to
the intracellular (bath) solution. (B) CFTRinh-172 concentration-inhibition
relationship under these conditions, showing the fraction of control current
remaining following addition of different concentrations of the inhibitor. The
data have been fitted by the equation: fractional current=1 / (1+{[inh]/Kd}
nH),
where [inh] is the concentration of CFTRinh-172, Kd is 0.63 μM, and nH, the
slope factor or Hill coefficient, is 0.83.
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by HCO3
− efflux (Fig. 3B). However, at hyperpolarized voltages
both glibenclamide and suramin were significantly less effective
at blocking HCO3
− currents compared to their effects on Cl−
currents (Fig. 3C).
Since these inhibitors act by occluding the Cl− permeation
pathway [31,32] these results are consistent with HCO3
− trans-
port through the Cl− channel pore. However, since many dif-
ferent anion channels and transporters show overlapping
sensitivity to inhibitors, this finding is not definitive of CFTR
pore-mediated transport. These mechanisms by which these in-
hibitors block Cl− permeation are known to involve interaction
with positively charged amino acid side chains in the CFTR
pore inner vestibule, and neutralization of these positive chargesby mutagenesis greatly reduces their blocking effects on CFTR
Cl− currents [31,32]. Fig. 4 shows that these same charge-
neutralizing mutations (K95Q, R303Q) also drastically reduce
the ability of these inhibitors to block HCO3
− currents under the
same ionic conditions used in Fig. 3 (50 mM HCO3
− intra-
cellular, 50 mM gluconate extracellular). Removal of one im-
portant positive charge in the K95Q mutant resulted in only
small HCO3
− currents that were often difficult to resolve, never-
theless, Fig. 4 indicates that this mutation dramatically reduced
the ability of both DNDS and glibenclamide to block HCO3
−
currents. Anothermutation, R303Q, greatlyweakened the block-
ing effects of suramin on HCO3
− currents. These effects of muta-
genesis within the pore are very similar to those previously
reported for block of Cl− currents [31,32] and suggest that blocker
molecules interacting with these residues and within the pore
inner vestibule physically blocks the passage of both Cl− and
HCO3
− ions through the channel.
3.3. Bicarbonate permeability of CF mutant forms of CFTR
Previously it was shown that some “severe” (pancreatic
insufficient; PI) CF mutations were associated with loss of
HCO3
− transport in spite of normal or even elevated Cl− trans-
port, whereas pancreatic sufficient (PS) CF mutations still
retained some HCO3
− transport [10]. While the association
between CF phenotype and HCO3
−/Cl− transport may not be so
straightforward [9], one possible explanation for this finding is
that these severe, PI mutant forms of CFTR had selectively lost
the ability to transport HCO3
−. Fig. 5 showsmacroscopic currents
carried by three of these mutants, two associated with loss of
cellular HCO3
− transport and PI disease (G178R, H620Q) and
one with retained HCO3
− transport and PS disease (G551 S) [10].
These currents were obtained under the same ionic conditions
(50 mMHCO3
− intracellular, 54 mMCl− extracellular) as shown
for wild type in Fig. 1B. It can be seen that each of these mutants
is capable of mediating HCO3
− efflux; in fact, reversal potential
measurements indicate PHCO3/PCl values of 0.289±0.038 (n=3)
for G178R, 0.264±0.035 (n=3) for G551S, and 0.237±0.033
(n=3) for H620Q, none of which were significantly different
from the value of 0.250±0.037 (n=4) estimated from wild type
under the same conditions (see Fig. 1B). Similar results were
obtained using 150 mM intracellular HCO3
− and 154 mM
extracellular Cl−, the same ionic conditions used in Fig. 1A (data
not shown).
4. Discussion
CFTR has the potential to contribute to epithelial HCO3
−
secretion both directly (by acting as a HCO3
−-permeable channel)
and indirectly (by regulating the activity of other membrane
HCO3
− transport proteins). Unfortunately, the relative impor-
tance of these two possible roles has been difficult to ascertain,
and as a result, their relevance to the defective HCO3
− secretion in
CF epithelia is unclear. We have focussed on the mechanism of
“direct” HCO3
− transport through the CFTR pore, measured
directly as the electrical current carried by HCO3
− ions as they
cross the membrane from the intracellular to the extracellular
Fig. 3. Block of chloride and bicarbonate currents (A, B) Example leak-subtracted macroscopic I–V relationships recorded with 54 mM Cl− (A) or 50 mM HCO3
− plus
4 mM Cl− in the intracellular solution, and 4 mM Cl− plus 50 mM gluconate in the extracellular solution. In each case, currents were recorded before (a) and following
(b) addition of the named CFTR channel blocker to the intracellular solution: DNDS (100 μM, left panels), glibenclamide (30 μM, centre panels), or suramin (10 μM,
right panels). (C) Mean fraction of control current remaining following addition of these concentrations of blockers, both for Cl− currents (○) and HCO3
− currents (●),
as a function of membrane potential. Asterisks indicate the voltage range over which the fractional block was significantly different for HCO3
− versus Cl− currents.
Mean of data from 3–5 patches.
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− secretion from
epithelial cells.
When studied in excised cell membranes containing a large
number of channels, CFTR is clearly capable of mediating
HCO3
− efflux directly (Fig. 1), consistent with earlier reports
that used high HCO3
− concentrations [11–13,30]. Interestingly,
HCO3
− efflux is conserved as HCO3
− concentration is lowered
(at least to 50 mM). It should be noted that this concentration
of HCO3
− is still far higher than in the cytoplasm of pancreatic
duct cells, where values of 15–25 mM have been reported
[15,16]. Furthermore, we find the HCO3
− permeability of the
channel to be very similar at high (154 mM) and low (4 mM)
extracellular Cl− concentrations. In fact, over the range of
HCO3
− and Cl− concentrations that we have studied, the relative
HCO3
− permeability of the channel (PHCO3/PCl) for currents
carried by HCO3
− efflux is consistently within the range0.23–0.29. Unfortunately, it is not possible to determine HCO3
−
permeability under more physiological conditions using elec-
trophysiological methods, due to the dominant effect of Cl− –
which may be present in the intracellular and lumenal fluid
of the unstimulated pancreatic duct at concentrations of ~60
and ~120 mM respectively [15,16] – on the predicted reversal
potential. Nevertheless, our results are consistent with HCO3
−
permeability of CFTR not being a strongly [HCO3
−]- or [Cl−]-
dependent parameter.
Both HCO3
− currents and Cl− currents appear to be mediated
by the same transport pathway in CFTR. Thus interactions be-
tween cytoplasmically applied open channel blockers (DNDS,
glibenclamide, suramin) and positively charged amino acid side
chains located within the permeation pathway (K95, R303)
result in block of both Cl− currents and HCO3
− currents (Fig. 4).
Small differences were observed in the ability of open channel
Fig. 4. Mutations in the pore decrease the blocker sensitivity of bicarbonate currents (A) Example leak-subtracted I–V relationship recorded under the same ionic
conditions used in Fig. 3B in K95Q-CFTR (left, centre panels) or R303Q-CFTR (right panel). In each case, currents were recorded before (a) and following (b)
addition of the named CFTR channel blocker to the intracellular solution: DNDS (100 μM, left panel), glibenclamide (30 μM, centre panel), or suramin (10 μM, right
panel), as shown for wild type CFTR in Fig. 3B. (B) Mean fraction of control current remaining following addition of these concentrations of blockers, in wild type
(●; taken from Fig. 3C) or the named mutant (○). In each case fractional block was significantly different in the named mutant versus wild type across the entire
voltage range studied. Mean of data from 3–5 patches.
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− versus Cl− currents, with both gliben-
clamide and suramin blocking Cl− currents significantly more
strongly than HCO3
− currents at some voltages (Fig. 3). How-
ever, this is not unexpected since interactions between blocking
and permeant ions inside the pore have been described many
times previously [3,33,34]. It is possible that intracellular HCO3
−
competes more effectively with blocking anions for sites in-
side the pore than does Cl−, resulting in weaker block of HCO3
−
permeation. We suggest that direct HCO3
− transport by CFTR is
via a common, relatively non-selective anion channel pore that
allows passage of both Cl− and HCO3
− ions, and that the mech-
anism of transport is effectively identical for both ions.
Our suggestion that HCO3
− and Cl− are transported by
a common mechanism seems contrary to previous suggestionsFig. 5. Bicarbonate permeability of CF mutant forms of CFTR Example leak-subtrac
the same ionic conditions used in Fig. 1B.that CFTR showed “dynamic” selectivity between Cl− and
HCO3
− ions [17,18]. However, these previous studies used re-
latively indirect measures of CFTR-dependent HCO3
− transport
– the transepithelial potential difference [17] or changes in
intracellular pH [18] – and as a result did not quantify CFTR
HCO3
− permeability directly. In contrast, we believe our patch
clamp experiments on excised membrane patches from cells
heterologously expressing a very high density of CFTR chan-
nels provides the most direct measure of CFTR-dependent
HCO3
− transport. This assertion is supported by the findings that
the current we record is strongly inhibited by CFTRinh-172
(Fig. 2) and that its blocker-sensitivity is affected by mutations
within the CFTR pore region (Fig. 4). We suggest that CFTR
itself shows an invariable ionic selectivity, and earlier studiested macroscopic I–V relationships for G178R, G551S, and H620Q-CFTR under
121L. Tang et al. / Journal of Cystic Fibrosis 8 (2009) 115–121[17,18] may have been reporting “dynamic” changes in some-
thing other than direct CFTR-mediated HCO3
− transport, for
example dynamic CFTR regulation of other HCO3
− transport
proteins.
Our direct measurements of CFTR HCO3
− currents also showed
no change in HCO3
− permeability in three CF-associated CFTR
mutants (G178R, G551S, H620Q; Fig. 5) that were previously
associatedwith different effects on cellular HCO3
− transport relative
to Cl− transport [10]. This result suggests that loss of direct HCO3
−
permeation through the channel is not responsible for the selective
loss of HCO3
− transport relative to Cl− transport previously asso-
ciated with the severe, PI mutations G178R and H620Q. We sug-
gest that the relatively selective loss of HCO3
− transport associated
with these mutations may be more due to a more indirect defi-
ciency, such as loss of regulation of Cl−/HCO3
− exchange pro-
teins [24]. This implies that CFTR's most important role in
HCO3
− transport – at least in the pancreas – might be as a
regulator of Cl−/HCO3
− exchange proteins, with direct HCO3
−
transport playing at most a minor role. Pancreatic disease in CF
patients would then result predominantly from loss of this
regulatory function of CFTR. Whether or not direct HCO3
−
transport via CFTR is more relevant to the physiology of other
organs, such as the airways [6], and to their pathophysiology in
CF, remains to be determined.
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